Terms: = Lung cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Treatment
32 results:
1. Therapeutic vaccines for advanced non-small cell lung cancer.
Cortés-Jofré M; Rueda-Etxebarria M; Orillard E; Jimenez Tejero E; Rueda JR
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD013377. PubMed ID: 38470132
[TBL] [Abstract] [Full Text] [Related]
2. Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (fancd2) in human tumors.
Xie X; Zhao Y; Du F; Cai B; Fang Z; Liu Y; Sang Y; Ma C; Liu Z; Yu X; Zhang C; Jiang J; Gao Z; Liu Y; Lin X; Jing H; Zhong X; Cong L; Dai H; Sha D; Shao N; Feng H; Li L; Liu J; Shang L
Genomics; 2024 Jan; 116(1):110762. PubMed ID: 38104669
[TBL] [Abstract] [Full Text] [Related]
3. Identification of arnicolide C as a novel chemosensitizer to suppress mTOR/E2F1/fancd2 axis in non-small cell lung cancer.
Chen YF; Pang YC; Wang HC; Wu PE; Chen ZJ; Huang D; Peng DL; Yan YM; Liu C; Wu LC; Fan XZ; Cheng YX; Liu YQ
Br J Pharmacol; 2024 Apr; 181(8):1221-1237. PubMed ID: 37926864
[TBL] [Abstract] [Full Text] [Related]
4. Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells.
Kopecka J; Barbanente A; Vitone D; Arnesano F; Margiotta N; Berchialla P; Niso M; Riganti C; Abate C
Pharmacol Rep; 2023 Dec; 75(6):1588-1596. PubMed ID: 37796435
[TBL] [Abstract] [Full Text] [Related]
5. Changes in the Proteome Profile of A549 Cells Following Helichrysetin-Induced Apoptosis Suggest the Involvement of DNA Damage Response and Cell Cycle Arrest-Associated Proteins.
Ho YF; Yajit NLM; Shiau JY; Malek SNA; Shyur LF; Karsani SA
Appl Biochem Biotechnol; 2023 Nov; 195(11):6867-6880. PubMed ID: 36947367
[TBL] [Abstract] [Full Text] [Related]
6. Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population.
Yu X; Zhao L; Song B
BMC Pulm Med; 2022 Nov; 22(1):431. PubMed ID: 36411438
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in lung Adenocarcinoma.
Yang C; Wei Y; Li W; Wei J; Chen G; Xu M; Liu G
J Immunol Res; 2022; 2022():6567916. PubMed ID: 35571564
[TBL] [Abstract] [Full Text] [Related]
8. Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway.
Fan XZ; Chen YF; Zhang SB; He DH; Wei SF; Wang Q; Pan HF; Liu YQ
Phytomedicine; 2021 Oct; 91():153689. PubMed ID: 34446320
[TBL] [Abstract] [Full Text] [Related]
9. Effect of patient-controlled intravenous analgesia combined with flurbiprofen axetil and dezocine on postoperative analgesia for lobectomy (EPIC-fad): a trial protocol.
Zhou J; Pu Q; Lin L; Chong W; Chen B; Hai Y; Liu F; Liu L
Trials; 2021 Mar; 22(1):175. PubMed ID: 33648558
[TBL] [Abstract] [Full Text] [Related]
10. Inactivation of ribosomal protein S27-like impairs DNA interstrand cross-link repair by destabilization of fancd2 and FANCI.
Sun S; He H; Ma Y; Xu J; Chen G; Sun Y; Xiong X
Cell Death Dis; 2020 Oct; 11(10):852. PubMed ID: 33051438
[TBL] [Abstract] [Full Text] [Related]
11. Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India.
Ghosh J; Ganguly S; Mondal D; Pandey P; Dabkara D; Biswas B
JCO Glob Oncol; 2020 Jun; 6():844-851. PubMed ID: 32552110
[TBL] [Abstract] [Full Text] [Related]
12. Role of the ERO1-PDI interaction in oxidative protein folding and disease.
Shergalis AG; Hu S; Bankhead A; Neamati N
Pharmacol Ther; 2020 Jun; 210():107525. PubMed ID: 32201313
[TBL] [Abstract] [Full Text] [Related]
13. [Stereotactic body radiotherapy: Passing fad or revolution?].
Vallard A; Vial N; Jmour O; Rehailia-Blanchard A; Trone JC; Sotton S; Daguenet E; Guy JB; Magné N
Bull Cancer; 2020 Feb; 107(2):244-253. PubMed ID: 31864665
[TBL] [Abstract] [Full Text] [Related]
14. Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.
Tacconi EM; Badie S; De Gregoriis G; Reisländer T; Lai X; Porru M; Folio C; Moore J; Kopp A; Baguña Torres J; Sneddon D; Green M; Dedic S; Lee JW; Batra AS; Rueda OM; Bruna A; Leonetti C; Caldas C; Cornelissen B; Brino L; Ryan A; Biroccio A; Tarsounas M
EMBO Mol Med; 2019 Jul; 11(7):e9982. PubMed ID: 31273933
[TBL] [Abstract] [Full Text] [Related]
15. A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human lung cancer Cells In Vitro.
Lee DE; Alhallak K; Jenkins SV; Vargas I; Greene NP; Quinn KP; Griffin RJ; Dings RPM; Rajaram N
Sci Rep; 2018 Jun; 8(1):8815. PubMed ID: 29891977
[TBL] [Abstract] [Full Text] [Related]
16. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastrointestinal cancers: fad or standard of care?
Teo MCC; Tan GHC
Singapore Med J; 2018 Mar; 59(3):116-120. PubMed ID: 29568842
[TBL] [Abstract] [Full Text] [Related]
17. Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine.
Dai CH; Wang Y; Chen P; Jiang Q; Lan T; Li MY; Su JY; Wu Y; Li J
Sci Rep; 2017 Nov; 7(1):15031. PubMed ID: 29118324
[TBL] [Abstract] [Full Text] [Related]
18. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
[TBL] [Abstract] [Full Text] [Related]
19. Optical imaging of radiation-induced metabolic changes in radiation-sensitive and resistant cancer cells.
Alhallak K; Jenkins SV; Lee DE; Greene NP; Quinn KP; Griffin RJ; Dings RPM; Rajaram N
J Biomed Opt; 2017 Jun; 22(6):60502. PubMed ID: 28622395
[TBL] [Abstract] [Full Text] [Related]
20. Celastrol induces proteasomal degradation of fancd2 to sensitize lung cancer cells to DNA crosslinking agents.
Wang GZ; Liu YQ; Cheng X; Zhou GB
Cancer Sci; 2015 Jul; 106(7):902-8. PubMed ID: 25891850
[TBL] [Abstract] [Full Text] [Related]
[Next]
